Understanding the Meiotic Competence of Oocytes Derived from Oogonial Stem Cells

Total Page:16

File Type:pdf, Size:1020Kb

Understanding the Meiotic Competence of Oocytes Derived from Oogonial Stem Cells UNIVERSITY OF SOUTHAMPTON FACULTY OF NATURAL AND ENVIRONMENTAL SCIENCES Biological Sciences Understanding the Meiotic Competence of Oocytes Derived from Oogonial Stem Cells by Larissa Zárate-García Thesis for the degree of Doctor of Philosophy June 2017 UNIVERSITY OF SOUTHAMPTON ABSTRACT FACULTY OF BIOLOGICAL AND ENVIRONMENTAL SCIENCES School of Biological Sciences Thesis for the degree of Doctor of Philosophy UNDERSTANDING THE MEIOTIC COMPETENCE OF OOCYTES DERIVED FROM OOGONIAL STEM CELLS By Larissa Zárate-García This thesis investigates whether Oogonial Stem Cells (OSCs) exist and can be isolated from the adult mouse ovary. It also examines their ability to differentiate into oocyte-like cells in vitro. Transmembrane domains in the DEAD-box polypeptide 4 (DDX4) – the germline marker used in this antibody-based isolation – are examined using in silico protein modelling. The specificity of this antibody to DDX4 is tested in male and female germline cells. It is shown that the DDX4 antibody may have some specificity for DDX4, but the existence of a surface-bound DDX4 is unlikely. OSC-like cells can be isolated from the ovary using the DDX4 antibody by Fluorescence-Activated Cell Sorting (FACS). However, gene expression analysis and protein immunofluorescence show that these cells do not initially express DDX4 or possess germline identity. Despite this, they acquire some pre-meiotic and oocyte-specific markers in culture, including DDX4. Critically, the cells never express meiosis-specific markers even in the presence of meiotic enhancers BMP4 and retinoic acid. It is unlikely that these ovarian cells are being sorted by means of a cell surface DDX4 expression, because another antibody to a larger DDX4 epitope fails to detect DDX4 in isolated cells. These findings highlight that freshly isolated OSCs are not germ stem cells, and are not being isolated by their DDX4 expression, but instead may reflect an artefact of the antibody used or procedure adopted. Altogether this work offers support to the established dogma that the adult ovary is populated at birth by a fixed number of oocytes, and that adult de novo production is a rare or insignificant event. Table of Contents List of Figures .................................................................................................................... vii List of Tables ...................................................................................................................... xi Declaration of Authorship .............................................................................................. xiii Acknowledgements ............................................................................................................ xv Definitions and Abbreviations ....................................................................................... xvii 1. Chapter 1: Introduction ............................................................................................ 1 1.1 General Considerations of the Female Mammalian Germline .............................. 1 1.2 Determination of Primordial Germ Cells in the Mouse Embryo ........................... 3 1.2.1 Role of Bone Morphogenetic Factors .............................................................. 3 1.2.2 Founding Primordial Germ Cells ..................................................................... 7 1.2.3 Further Modifications and Migration Towards the Genital Ridges ................. 8 1.3 Determination of Female Germ Stem Cells ......................................................... 10 1.3.1 Formation of Intercellular Bridges in Germ Cells ......................................... 10 1.3.2 Activation of Secondary Germline-specific Markers ..................................... 11 1.4 Meiosis and Folliculogenesis ............................................................................... 12 1.4.1 Role of Retinoic Acid .................................................................................... 12 1.4.2 Onset of Meiosis ............................................................................................. 15 1.4.3 Prophase I, Chromosome Recombination and First Meiotic Arrest .............. 16 1.4.4 Formation of Germinal Vesicle Oocytes and Perinatal Apoptosis of Female Germ Stem Cells ............................................................................................ 17 1.4.5 Primordial Follicle Assembly and Establishment of Follicle Reserve ........... 18 1.4.6 Primary to Pre-antral Follicle Growth ............................................................ 19 1.4.7 Graafian Follicles, Germinal Vesicle Breakdown and Second Meiotic Arrest 20 1.4.8 Cumulus Expansion, Ovulation and Resumption of Metaphase II ................ 21 1.5 Stem Cells in Animals ......................................................................................... 22 1.5.1 Classification and History of Stem Cells ....................................................... 23 1.5.2 In Vivo Pluripotency/Differentiation Balance in Stem Cells ......................... 24 1.5.3 Methods to Derive Embryonic Stem Cell Cultures ....................................... 26 1.5.4 In Vivo Maintenance of Pluripotency, Proliferation and Self-renewal .......... 28 1.5.5 In Vitro Differentiation of Embryonic and Induced Pluripotent Stem Cells .. 30 1.5.6 Oocyte-like cells from Embryonic and Induced Pluripotent Stem Cells ....... 30 1.6 Germ Stem Cells in the Adult Mammal Ovary ................................................... 31 i 1.6.1 Early Studies on De Novo Oogenesis ............................................................ 31 1.6.2 Early Mathematical Models of Follicular Dynamics ..................................... 33 1.6.3 Modern Mathematical Models of Follicular Dynamics ................................ 35 1.7 The Bone Marrow as a Source of Germ Stem Cells ........................................... 37 1.8 Oocytes Obtained from Adult Oogonial Stem Cells ........................................... 40 1.8.1 Ddx4-based Method for OSCs Isolation ........................................................ 40 1.8.2 Ifitm3- and Pou5f1-based Methods for OSCs Isolation ................................. 43 1.8.3 Studies Not Supporting the Existence of OSCs ............................................ 44 1.9 Thesis Aims ......................................................................................................... 45 1.9.1 Do OSCs exist? ............................................................................................. 45 1.9.2 Can they provide us with oocytes? ................................................................ 46 1.9.3 Are these oocytes meiotically competent cells? ............................................ 46 2. Chapter 2: General Materials and Methods ........................................................ 49 2.1 Mice ..................................................................................................................... 49 2.1.1 Ethics ............................................................................................................. 49 2.1.2 Mice ............................................................................................................... 49 2.1.3 Hormonal Priming ......................................................................................... 49 2.1.4 Tissue Collection ........................................................................................... 50 2.2 Oocyte Handling and Collection ......................................................................... 50 2.2.1 Manufacture of Mouth Pipetting System ...................................................... 50 2.2.2 GV Oocyte Handling and Collection ............................................................. 51 2.2.3 MII Oocyte Handling and Collection ............................................................ 51 2.2.4 Enzymatic Digestion of Organs ..................................................................... 51 2.3 Gene Expression Analysis ................................................................................... 52 2.3.1 Total RNA Extraction from Oocytes ............................................................. 52 2.3.2 Total RNA Extraction from Tissue and Cell Suspensions ............................ 52 2.3.3 Complementary DNA Synthesis .................................................................... 53 2.3.4 Real-Time Polymerase Chain Reaction ......................................................... 53 2.3.5 Agarose Gel Electrophoresis .......................................................................... 55 2.4 Western Blot ........................................................................................................ 55 2.4.1 Protein Extraction and Measurement ............................................................. 55 2.4.2 SDS-PAGE Gel Running ............................................................................... 55 2.4.3 Transfer of Proteins to Nitrocellulose Membranes ........................................ 56 2.5 Cell Culture ......................................................................................................... 56 ii 2.5.1 Control Culture Media (CM) .......................................................................... 56 2.5.2 OSC Culture Media (OSCM) ......................................................................... 56 2.5.3 MEF Growth Culture Medium ....................................................................... 57 2.5.4 Coating of Culture Dish Surfaces
Recommended publications
  • When Stem Cells Grow Old: Phenotypes and Mechanisms of Stem Cell Aging Michael B
    © 2016. Published by The Company of Biologists Ltd | Development (2016) 143, 3-14 doi:10.1242/dev.130633 REVIEW When stem cells grow old: phenotypes and mechanisms of stem cell aging Michael B. Schultz and David A. Sinclair* ABSTRACT Thus, a stark collapse of the hematological system does not occur All multicellular organisms undergo a decline in tissue and organ during normal aging. However, when murine HSCs with long-term + − function as they age. An attractive theory is that a loss in stem cell repopulating ability were isolated by selecting for c-Kit , lineage + number and/or activity over time causes this decline. In accordance (multiple markers), Sca-1 cells (KLS) (Ikuta and Weissman, 1992; with this theory, aging phenotypes have been described for stem cells Spangrude et al., 1988), the number of HSCs was found to steadily of multiple tissues, including those of the hematopoietic system, increase with age (de Haan et al., 1997; Morrison et al., 1996). Only intestine, muscle, brain, skin and germline. Here, we discuss recent when function was measured on a per-cell basis were old advances in our understanding of why adult stem cells age and how immunophenotypic HSCs shown to have a greatly reduced ability this aging impacts diseases and lifespan. With this increased to engraft and properly differentiate in new hosts (Dykstra et al., understanding, it is feasible to design and test interventions that 2011; Liang et al., 2005; Morrison et al., 1996). Furthermore, in delay stem cell aging and improve both health and lifespan. both mice and humans, the proportion of differentiated blood cells arising from just a few HSC clones increases, suggesting that the KEY WORDS: Age-related diseases, Hematopoietic stem cells, number of active, functional HSCs declines with age (Beerman Multicellular organisms et al., 2010; Genovese et al., 2014; Jaiswal et al., 2014).
    [Show full text]
  • Product Information
    Product information NANOG 1-154aa Human, His-tagged, Recombinant, E.coli Cat. No. IBATGP1124 Full name: Homeobox protein NANOG NCBI Accession No.: NP_079141 Synonyms: Homeobox transcription factor Nanog, homeobox transcription factor Nanog-delta 48 Description: NANOG, also known as nanog homeobox, is a member of the homeobox family of DNA binding transcription factors that has been shown to maintain pluripotency of embryonic stem cells. Nanog expression counteracts the differentiation-promoting signals induced by the extrinsic factors LIF, Stat3 and BMP. Once NANOG expression is down-regulated, cell differentiation can proceed. Recombinant human NANOG protein, fused to His- tag at N-terminus, was expressed in E.coli and purified by using conventional chromatography. Form: Liquid. 20mM Tris-HCl buffer (pH8.0) containing 20% glycerol, 1mM DTT Molecular Weight: 19.6 kDa (174aa), confirmed by MALDI-TOF (Molecular weight on SDS-PAGE will appear higher) Purity: > 90% by SDS - PAGE Concentration: 0.25 mg/ml (determined by Bradford assay) 15% SDS-PAGE (3ug) Sequences of amino acids: MGSSHHHHHH SSGLVPRGSH MSVDPACPQS LPCFEASDCK ESSPMPVICG PEENYPSLQM SSAEMPHTET VSPLPSSMDL LIQDSPDSST SPKGKQPTSA EKSVAKKEDK VPVKKQKTRT VFSSTQLCVL NDRFQRQKYL SLQQMQELSN ILNLSYKQVK TWFQNQRMKS KRWQ General references: Clark A T., et al. (2004) Stem Cells. 22:169-179. Chambers I., et al. (2003) Cell Res. 13:499-502. Storage: Can be stored at +4°C short term (1-2 weeks). For long term storage, aliquot and store at -20°C or -70°C. Avoid repeated freezing and thawing cycles. For research use only. This product is not intended or approved for human, diagnostics or veterinary use. Immuno-Biological Laboratories, Inc. (IBL-America) 8201 Central Ave.
    [Show full text]
  • Role of Mitochondrial Ribosomal Protein S18-2 in Cancerogenesis and in Regulation of Stemness and Differentiation
    From THE DEPARTMENT OF MICROBIOLOGY TUMOR AND CELL BIOLOGY (MTC) Karolinska Institutet, Stockholm, Sweden ROLE OF MITOCHONDRIAL RIBOSOMAL PROTEIN S18-2 IN CANCEROGENESIS AND IN REGULATION OF STEMNESS AND DIFFERENTIATION Muhammad Mushtaq Stockholm 2017 All previously published papers were reproduced with permission from the publisher. Published by Karolinska Institutet. Printed by E-Print AB 2017 © Muhammad Mushtaq, 2017 ISBN 978-91-7676-697-2 Role of Mitochondrial Ribosomal Protein S18-2 in Cancerogenesis and in Regulation of Stemness and Differentiation THESIS FOR DOCTORAL DEGREE (Ph.D.) By Muhammad Mushtaq Principal Supervisor: Faculty Opponent: Associate Professor Elena Kashuba Professor Pramod Kumar Srivastava Karolinska Institutet University of Connecticut Department of Microbiology Tumor and Cell Center for Immunotherapy of Cancer and Biology (MTC) Infectious Diseases Co-supervisor(s): Examination Board: Professor Sonia Lain Professor Ola Söderberg Karolinska Institutet Uppsala University Department of Microbiology Tumor and Cell Department of Immunology, Genetics and Biology (MTC) Pathology (IGP) Professor George Klein Professor Boris Zhivotovsky Karolinska Institutet Karolinska Institutet Department of Microbiology Tumor and Cell Institute of Environmental Medicine (IMM) Biology (MTC) Professor Lars-Gunnar Larsson Karolinska Institutet Department of Microbiology Tumor and Cell Biology (MTC) Dedicated to my parents ABSTRACT Mitochondria carry their own ribosomes (mitoribosomes) for the translation of mRNA encoded by mitochondrial DNA. The architecture of mitoribosomes is mainly composed of mitochondrial ribosomal proteins (MRPs), which are encoded by nuclear genomic DNA. Emerging experimental evidences reveal that several MRPs are multifunctional and they exhibit important extra-mitochondrial functions, such as involvement in apoptosis, protein biosynthesis and signal transduction. Dysregulations of the MRPs are associated with severe pathological conditions, including cancer.
    [Show full text]
  • Cell Cycle and Pluripotency: Convergence on Octamer‑Binding Transcription Factor 4 (Review)
    MOLECULAR MEDICINE REPORTS 16: 6459-6466, 2017 Cell cycle and pluripotency: Convergence on octamer‑binding transcription factor 4 (Review) SHIQI SHE1*, QUCHENG WEI2*, BO KANG1 and YING-JIE WANG1 1State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003; 2Cardiovascular Key Lab of Zhejiang, Department of Cardiology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310009, P.R. China Received December 17, 2016; Accepted July 14, 2017 DOI: 10.3892/mmr.2017.7489 Abstract. Embryonic stem cells (ESCs) have unlimited expan- 1. Introduction sion potential and the ability to differentiate into all somatic cell types for regenerative medicine and disease model studies. Embryonic stem cells (ESCs) are characterized by unlimited Octamer-binding transcription factor 4 (OCT4), encoded by proliferation (self-renewal) and the ability to differentiate into the POU domain, class 5, transcription factor 1 gene, is a tran- three primary germ layers, namely the endoderm, mesoderm scription factor vital for maintaining ESC pluripotency and and ectoderm (pluripotency) (1-4). It has been established somatic reprogramming. Many studies have established that that complicated regulatory networks are present in ESCs the cell cycle of ESCs is featured with an abbreviated G1 phase that critically maintain the state of self-renewal and pluri- and a prolonged S phase. Changes in cell cycle dynamics are potency for later development (5,6). Several transcription intimately associated with the state of ESC pluripotency, and factors (TFs), including octamer-binding transcription factor manipulating cell-cycle regulators could enable a controlled 4 (OCT4), SRY-box 2 (SOX2) and homeobox protein NANOG differentiation of ESCs.
    [Show full text]
  • This Thesis Has Been Submitted in Fulfilment of the Requirements for a Postgraduate Degree (E.G
    This thesis has been submitted in fulfilment of the requirements for a postgraduate degree (e.g. PhD, MPhil, DClinPsychol) at the University of Edinburgh. Please note the following terms and conditions of use: This work is protected by copyright and other intellectual property rights, which are retained by the thesis author, unless otherwise stated. A copy can be downloaded for personal non-commercial research or study, without prior permission or charge. This thesis cannot be reproduced or quoted extensively from without first obtaining permission in writing from the author. The content must not be changed in any way or sold commercially in any format or medium without the formal permission of the author. When referring to this work, full bibliographic details including the author, title, awarding institution and date of the thesis must be given. Isolation, Characterisation and In Vitro Potential of Oogonial Stem Cells Cheryl Elizabeth Dunlop BSc Med Sci (Hons), University of Edinburgh MBChB (Hons), University of Edinburgh Doctor of Philosophy (PhD) – The University of Edinburgh – 2016 Declaration This thesis has been composed by myself and the research described herein is my own, except where work by others has been duly acknowledged. The work described in this thesis has not been submitted for any other degree or professional qualification. Cheryl Dunlop 2016 i Abstract The longstanding belief that women are born with a finite ovarian reserve has been debated for over a decade, ever since the discovery, and subsequent isolation, of purported oogonial stem cells (OSCs) from adult mammalian ovaries. This rare cell population has now been reported in the mouse, rat, pig, rhesus macaque monkey and humans and, although a physiological role for the cells has not been proven, they do appear to generate oocytes when cultured in specific environments, resulting in live offspring in rodents.
    [Show full text]
  • WO 2013/002880 Al O O© O
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2013/002880 Al 3 January 2013 (03.01.2013) P O P C T (51) International Patent Classification: (74) Agents: LAURO, Peter C. et al; Edwards Wildman C12N 5/00 (2006.01) C12N 5/075 (2010.01) Palmer LLP, P.O. Box 55874, Boston, MA 02205 (US). (21) International Application Number: (81) Designated States (unless otherwise indicated, for every PCT/US2012/033672 kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, (22) Date: International Filing CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, 13 April 2012 (13.04.2012) DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, (25) Filing Language: English HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, (26) Publication Language: English MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, (30) Priority Data: OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, 61/502,840 29 June 201 1 (29.06.201 1) US SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, 61/600,529 17 February 2012 (17.02.2012) US TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (71) Applicants (for all designated States except US): THE (84) Designated States (unless otherwise indicated, for every GENERAL HOSPITAL CORPORATION [US/US]; 55 kind of regional protection available): ARIPO (BW, GH, Fruit Street, Boston, MA 021 14 (US).
    [Show full text]
  • Studies Relating to the Differentiation of Human Embryonic Stem Cells
    Studies relating to the differentiation of human embryonic stem cells A thesis submitted to the University of Manchester for the degree of Doctor of Philosophy in the Faculty of Life Sciences 2015 Georgios Anyfantis List of Figures .................................................................................................... 10 List of Tables ...................................................................................................... 13 Declaration ........................................................................................................ 15 Copyright statement .......................................................................................... 15 Acknowledgements ........................................................................................... 16 Abbreviations .................................................................................................... 17 Chapter 1: Introduction ...................................................................................... 23 1.1 Diabetes Mellitus ......................................................................................... 23 1.2 Pancreatic function and Organogenesis ........................................................ 24 1.2.1 Pancreatic Function .................................................................................... 24 1.2.2 Pancreatic Organogenesis ........................................................................... 26 1.3 Signalling Pathways associated with pancreas development .......................
    [Show full text]
  • Stem Cells/ Cloning Michael K
    Spring 2018 – Systems Biology of Reproduction Lecture Outline – Gametogenesis/ Stem Cells/ Cloning Michael K. Skinner – Biol 475/575 CUE 418, 10:35-11:50 am, Tuesday & Thursday March 20, 2018 Week 11 Gametogenesis/ Stem Cells/ Cloning - Gametogenesis - Spermatogenesis - Cell Development Stages - Meiosis - Male Germline Stem Cell and Niche - Cell Biology - Niche - Regulatory Factors - Germ Cell Transplantation - Oogenesis - Cell Development - Meiosis - Female Germline Stem Cells - Embryonic Stem Cells - Cloning REFERENCES Ahn J, Park YJ, Chen P, et al. (2017) Comparative expression profiling of testis-enriched genes regulated during the development of spermatogonial cells. PLoS One. 12(4):e0175787. Vicens A, Borziak K, Karr TL, Roldan ERS, Dorus S. (2017) Comparative Sperm Proteomics in Mouse Species with Divergent Mating Systems. Mol Biol Evol. 34(6):1403-1416. Goldmann JM, Wong WS, Pinelli M, et al (2016) Parent-of-origin-specific signatures of de novo mutations. Nat Genet. 48(8):935-9 Virant-Klun I, Leicht S, Hughes C, Krijgsveld J. (2016) Identification of Maturation- Specific Proteins by Single-Cell Proteomics of Human Oocytes. Mol Cell Proteomics. 15(8):2616-27. Ball RL, Fujiwara Y, Sun F, Hu J, Hibbs MA, Handel MA, Carter GW. (2016) Regulatory complexity revealed by integrated cytological and RNA-seq analyses of meiotic substages in mouse spermatocytes. BMC Genomics. 17(1):628. Totonchi M, Hassani SN, Sharifi-Zarchi A, et al. (2017) Blockage of the Epithelial-to- Mesenchymal Transition Is Required for Embryonic Stem Cell Derivation. Stem Cell Reports. 9(4):1275-1290. Pal D, Rao MRS. (2017) Long Noncoding RNAs in Pluripotency of Stem Cells and Cell Fate Specification.
    [Show full text]
  • Open Hester Dissertation W Appendix.Pdf
    The Pennsylvania State University The Graduate School Intercollege Graduate Degree Program in Physiology THE IMPACT OF ZINC DEFICIENCY DURING OOGENESIS, FOLLICLE ASSEMBLY, AND GROWTH A Dissertation in Integrative and Biomedical Physiology by James M. Hester 2018 James Hester Submitted in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy December 2018 ii The dissertation of James Hester was reviewed and approved* by the following: Francisco J. Diaz Associate Professor of Reproductive Biology Dissertation Advisor Chair of Committee Wendy Hanna-Rose Associate Professor and Department Head Biochemistry and Molecular Biology Alan L. Johnson Walther H. Ott Professor in Avian Biology Claire M. Thomas Associate Professor of Biology and Biochemistry and Molecular Biology Donna H. Korzick Professor of Physiology and Kinesiology Chair, Intercollege Graduate Degree Program in Physiology *Signatures are on file in the Graduate School iii ABSTRACT The ovarian follicle is the fundamental unit of the ovary and of female reproduction in mammals. Each follicle contains one oocyte enclosed in somatic cells and follicle number is determined during fetal development in humans. Growth and development of ovarian follicles (folliculogenesis) is necessary to produce viable gametes as well as ovarian hormones including estrogen and progesterone. Folliculogenesis begins in the fetal ovary and may span several decades of life. Environmental and nutritional factors that affect folliculogenesis have the potential to impact health and fertility, and may be a source of new biotechnological innovation. One such factor, zinc, has previously been found to impact the final stages of follicle development including meiotic division, ovulation, epigenetic modification, fertilization, and embryo development. However, the role of zinc during the early stages of folliculogenesis have not been evaluated.
    [Show full text]
  • FACS-Sorted Putative Oogonial Stem Cells from the Ovary Are Neither
    www.nature.com/scientificreports OPEN FACS-sorted putative oogonial stem cells from the ovary are neither DDX4-positive nor germ Received: 30 March 2016 Accepted: 26 May 2016 cells Published: 15 June 2016 Larissa Zarate-Garcia, Simon I. R. Lane, Julie A. Merriman & Keith T. Jones Whether the adult mammalian ovary contains oogonial stem cells (OSCs) is controversial. They have been isolated by a live-cell sorting method using the germ cell marker DDX4, which has previously been assumed to be cytoplasmic, not surface-bound. Furthermore their stem cell and germ cell characteristics remain disputed. Here we show that although OSC-like cells can be isolated from the ovary using an antibody to DDX4, there is no good in silico modelling to support the existence of a surface-bound DDX4. Furthermore these cells when isolated were not expressing DDX4, and did not initially possess germline identity. Despite these unremarkable beginnings, they acquired some pre- meiotic markers in culture, including DDX4, but critically never expressed oocyte-specific markers, and furthermore were not immortal but died after a few months. Our results suggest that freshly isolated OSCs are not germ stem cells, and are not being isolated by their DDX4 expression. However it may be that culture induces some pre-meiotic markers. In summary the present study offers weight to the dogma that the adult ovary is populated by a fixed number of oocytes and that adultde novo production is a rare or insignificant event. The prevailing dogma in the field of reproductive biology for over 60 years has been that the adult mammalian ovary lacks germ stem cells1.
    [Show full text]
  • Human Cell Modeling for Cardiovascular Diseases
    International Journal of Molecular Sciences Review Human Cell Modeling for Cardiovascular Diseases Melania Lippi 1, Ilaria Stadiotti 1, Giulio Pompilio 1,2 and Elena Sommariva 1,* 1 Unit of Vascular Biology and Regenerative Medicine, Centro Cardiologico Monzino IRCCS, 20138 Milan, Italy; [email protected] (M.L.); [email protected] (I.S.); [email protected] (G.P.) 2 Department of Clinical Sciences and Community Health, Università degli Studi di Milano, 20122 Milan, Italy * Correspondence: [email protected]; Tel.: +39-02-58002026; Fax: +39-02-58002342 Received: 13 August 2020; Accepted: 31 August 2020; Published: 2 September 2020 Abstract: The availability of appropriate and reliable in vitro cell models recapitulating human cardiovascular diseases has been the aim of numerous researchers, in order to retrace pathologic phenotypes, elucidate molecular mechanisms, and discover therapies using simple and reproducible techniques. In the past years, several human cell types have been utilized for these goals, including heterologous systems, cardiovascular and non-cardiovascular primary cells, and embryonic stem cells. The introduction of induced pluripotent stem cells and their differentiation potential brought new prospects for large-scale cardiovascular experiments, bypassing ethical concerns of embryonic stem cells and providing an advanced tool for disease modeling, diagnosis, and therapy. Each model has its advantages and disadvantages in terms of accessibility, maintenance, throughput, physiological relevance, recapitulation of the disease. A higher level of complexity in diseases modeling has been achieved with multicellular co-cultures. Furthermore, the important progresses reached by bioengineering during the last years, together with the opportunities given by pluripotent stem cells, have allowed the generation of increasingly advanced in vitro three-dimensional tissue-like constructs mimicking in vivo physiology.
    [Show full text]
  • Genetic Studies in Mice Directly Link Oocytes Produced During Adulthood
    www.nature.com/scientificreports OPEN Genetic studies in mice directly link oocytes produced during adulthood to ovarian function and natural Received: 23 June 2017 Accepted: 1 August 2017 fertility Published: xx xx xxxx Ning Wang1,2, Chonthicha Satirapod1,2, Yasuyo Ohguchi1,2, Eun-Sil Park3,4, Dori C. Woods3 & Jonathan L. Tilly3 Multiple labs have reported that mammalian ovaries contain oogonial stem cells (OSCs), which can diferentiate into oocytes that fertilize to produce ofspring. However, the physiological relevance of these observations to adult ovarian function is unknown. Here we performed targeted and reversible ablation of premeiotic germ cells undergoing diferentiation into oocytes in transgenic mice expressing the suicide gene, herpes simplex virus thymidine kinase (HSVtk), driven by the promoter of stimulated by retinoic acid gene 8 (Stra8), a germ cell-specifc gene activated during meiotic commitment. Over a 21-day ablation phase induced by the HSVtk pro-drug, ganciclovir (GCV), oocyte numbers declined due to a disruption of new oocyte input. However, germ cell diferentiation resumed after ceasing the ablation protocol, enabling complete regeneration of the oocyte pool. We next employed inducible lineage tracing to fate map, through Cre recombinase-mediated fuorescent reporter gene activation only in Stra8-expressing cells, newly-formed oocytes. Induction of the system during adulthood yielded a mosaic pool of unmarked (pre-existing) and marked (newly-formed) oocytes. Marked oocytes matured and fertilized to produce ofspring, which grew normally to adulthood and transmitted the reporter to second-generation ofspring. These fndings establish that oocytes generated during adulthood contribute directly to ovarian function and natural fertility in mammals.
    [Show full text]